142 related articles for article (PubMed ID: 19034280)
21. Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies.
Le TT; Gardner J; Hoang-Le D; Schmidt CW; MacDonald KP; Lambley E; Schroder WA; Ogbourne SM; Suhrbier A
Vaccine; 2009 May; 27(23):3053-62. PubMed ID: 19428919
[TBL] [Abstract][Full Text] [Related]
22. Semisynthetic Esters of 17-Hydroxycativic Acid with in Vitro Cytotoxic Activity against Leukemia Cell Lines.
Cavallaro V; Řezníčková E; Jorda R; Alza NP; Murray AP; Kryštof V
Biol Pharm Bull; 2017; 40(11):1923-1928. PubMed ID: 29093339
[TBL] [Abstract][Full Text] [Related]
23. The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature.
Li L; Shukla S; Lee A; Garfield SH; Maloney DJ; Ambudkar SV; Yuspa SH
Cancer Res; 2010 Jun; 70(11):4509-19. PubMed ID: 20460505
[TBL] [Abstract][Full Text] [Related]
24. Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine.
Temmink OH; Hoebe EK; Fukushima M; Peters GJ
Eur J Cancer; 2007 Jan; 43(1):175-83. PubMed ID: 17049227
[TBL] [Abstract][Full Text] [Related]
25. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.
Tillman DM; Izeradjene K; Szucs KS; Douglas L; Houghton JA
Cancer Res; 2003 Aug; 63(16):5118-25. PubMed ID: 12941843
[TBL] [Abstract][Full Text] [Related]
26. Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines.
Silva VAO; Rosa MN; Martinho O; Tanuri A; Lima JP; Pianowski LF; Reis RM
Invest New Drugs; 2019 Oct; 37(5):1029-1035. PubMed ID: 30706338
[TBL] [Abstract][Full Text] [Related]
27. Distinct protein kinase C isozymes signal mitogenesis and apoptosis in human colon cancer cells.
Weller SG; Klein IK; Penington RC; Karnes WE
Gastroenterology; 1999 Oct; 117(4):848-57. PubMed ID: 10500067
[TBL] [Abstract][Full Text] [Related]
28. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure.
La Porta CA; Dolfini E; Comolli R
Br J Cancer; 1998 Nov; 78(10):1283-7. PubMed ID: 9823967
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the interaction of ingenol 3-angelate with protein kinase C.
Kedei N; Lundberg DJ; Toth A; Welburn P; Garfield SH; Blumberg PM
Cancer Res; 2004 May; 64(9):3243-55. PubMed ID: 15126366
[TBL] [Abstract][Full Text] [Related]
31. Ectopic expression of protein kinase C-β sensitizes head and neck squamous cell carcinoma to diterpene esters.
Adams RA; D'Souza MM; Pierce CJ; Korica N; Wallwork B; Parsons PG; Panizza B; Boyle GM
Anticancer Res; 2015 Mar; 35(3):1291-6. PubMed ID: 25750277
[TBL] [Abstract][Full Text] [Related]
32. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
Rao AS; Freemerman AJ; Jarvis WD; Chelliah J; Bear HD; Mikkelsen R; Grant S
Leukemia; 1996 Jul; 10(7):1150-8. PubMed ID: 8683995
[TBL] [Abstract][Full Text] [Related]
33. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells.
Meinhardt G; Eppinger E; Schmidmaier R
Anticancer Drugs; 2002 Aug; 13(7):725-33. PubMed ID: 12187329
[TBL] [Abstract][Full Text] [Related]
34. Diterpenoid C of Radix Curcumae: an inhibitor of proliferation and inducer of apoptosis in human colon adenocarcinoma cells acting via inhibiting MAPK signaling pathway.
Shen Y; Lu B; Zhang S; Ma ZJ
Pharm Biol; 2014 Sep; 52(9):1158-65. PubMed ID: 24646305
[TBL] [Abstract][Full Text] [Related]
35. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells.
Lin SY; Liang YC; Ho YS; Tsai SH; Pan S; Lee WS
Mol Carcinog; 2002 Sep; 35(1):21-8. PubMed ID: 12203364
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
37. Effects of the PKC inhibitor PD 406976 on cell cycle progression, proliferation, PKC isozymes and apoptosis in glioma and SVG-transformed glial cells.
Russell C; Acevedo-Duncan M
Cell Prolif; 2005 Apr; 38(2):87-106. PubMed ID: 15842253
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9,13,14-ortho-phenylacetate in intestinal epithelial cells.
Frey MR; Clark JA; Bateman NW; Kazanietz MG; Black AR; Black JD
Biochem Pharmacol; 2004 May; 67(10):1873-86. PubMed ID: 15130764
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
Meinhardt G; Roth J; Totok G
Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
[TBL] [Abstract][Full Text] [Related]
40. Proceedings of the First International Conference on PEP005.
Ogbourne SM; Hampson P; Lord JM; Parsons P; De Witte PA; Suhrbier A
Anticancer Drugs; 2007 Mar; 18(3):357-62. PubMed ID: 17264770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
